Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu konsensus - konference, časopisecké články, přehledy
PubMed
40390594
DOI
10.1093/eurheartj/ehaf222
PII: 8138121
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, Myocarditis, Pericardial effusion, Pericarditis,
- MeSH
- COVID-19 * komplikace prevence a kontrola MeSH
- kardiologie MeSH
- konsensus MeSH
- lidé MeSH
- myokarditida * etiologie terapie diagnóza epidemiologie MeSH
- perikarditida etiologie terapie MeSH
- SARS-CoV-2 MeSH
- vakcinace * škodlivé účinky MeSH
- vakcíny proti COVID-19 * škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- konsensus - konference MeSH
- přehledy MeSH
- Geografické názvy
- Evropa MeSH
- Názvy látek
- vakcíny proti COVID-19 * MeSH
The aim of the present clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases is to review the current knowledge on the epidemiology, pathogenesis, diagnosis, therapy, and outcomes of myocardial and pericardial complications of coronavirus disease 2019 (COVID-19) and vaccination in order to improve the awareness and clinical confidence on the management of patients with these complications. The risk of myopericardial complications is especially higher within 1 month of COVID-19 disease and vaccination. Forms related to the disease are generally more common and severe than those related to vaccination. Even if vaccination against COVID-19 increases myocarditis risk, this risk is lower in vaccinated than non-vaccinated COVID-19 individuals, supporting the vaccine use. Overall, COVID-19 related complications, especially myocarditis, are relatively rare.
Berlin Institute of Health Berlin Germany
Cardiology University of Siena Siena Italy
CardioThoracoVascular Department Azienda Sanitaria Universitaria Giuliano Isontina Trieste Italy
Cellular and Molecular Cardiology Lab IRCCS L Spallanzani Rome Italy
Center for Molecualr Cardiology University of Zurich Switzerland
CMR Services Brompton Royal Hospital London UK
Department of Adult Cardiology Mitera Hospital Hygeia Group Athens Greece
Department of Biomedical and Clinical Sciences University of Milan Milan Italy
Department of Cardiology Angiology and Intensive Medicine Berlin Germany
Department of Cardiology Hospital Clínic de Barcelona IDIBAPS Barcelona Spain
Department of Medicine and Clinical Research Kuopio University Hospital Kuopio Finland
Department of Medicine and Surgery University of Milano Bicocca Milan Italy
Department of Medicine University of Udine Udine Italy
Deutsches Zentrum für Herzkreislaufforschung Partner Side Berlin Germany
Faculty of Medicine Vita Salute San Raffaele University Milan Italy
Royal Brompton and Harefield Hospitals Guy's and St Thomas' NHS Foundation Trust London UK
Sackler Faculty of Medicine Tel Aviv University Israel
University of Trieste member of ERN Guard Heart Trieste Italy
Citace poskytuje Crossref.org